<style face="normal" font="default" size="100%">1170 Development of a fusion protein bispecific for a CMV-specific TCR and CD19 which selectively activates and expands CMV-specific CTLs and redirects them to eliminate B cell leukemia cells</style>

Drupal-HighWire